HOME >> BIOLOGY >> NEWS
Genetic defenders protect crops from fungal disease

STANFORD, CA Like waves of soldiers guarding a castle gate, multiple genetic defenders cooperate to protect plant cells against powdery mildew disease, according to a new study. Powdery mildew is a common fungal infection in plants that attacks more than 9,000 species, including many crops such as barley and wheat, and horticultural plants such as roses and cucumbers. The researchers, including Shauna Somerville and Mnica Stein of the Carnegie Institution's Department of Plant Biology, are the first to document how these defense genes team up in plants. The discovery could help combat fungal parasites that devastate crops and cost growers billions of dollars in pesticides every year.

The study, published in the November 18 issue of the journal Science, describes powdery mildew infection in the mustard relative Arabidopsis thaliana. Each species of mildew is host-specific, meaning it can infect some plant species, but not others. By disabling protective genes in Arabidopsis, the researchers were able to infect the plants with species of powdery mildew that normally attack peas or barley, revealing much about how plants use genes to fight infection.

"Most plants are resistant to the majority of pathogens they encounter, but the basis for this resistance was unknown," Somerville said. "Identifying these genes has provided us with the first insight into how plants defend against multiple pathogens."

Once a powdery mildew infection takes hold, it covers the plant with fuzzy splotches, while sapping precious nutrients. At the cellular level, the fungal spores invade healthy plant cells and form root-like feeding structures called haustoria. The plant cell wall is the primary barrier to this invasion and one of the defense genes described in the current study, called PEN2, prevents the fungus from penetrating cell walls in the first place.

If this first line of defense breaks down, as it does in about 5 to 25 percent of normal Arabidopsis
'"/>

Contact: Dr. Shauna Somerville
ssomerville@stanford.edu
650-325-1521 x257
Carnegie Institution
17-Nov-2005


Page: 1 2 3

Related biology news :

1. Genetic variation helps to understand predisposition to schizophrenia
2. Genetic factors strongly shape how peers are chosen
3. Genetic analysis finds greater threat in frog-killing fungus
4. Genetic diversity in honeybee colonies boosts productivity
5. 2007-2008 Genzyme/ACMGF Clinical Genetics Fellowship In Biochemical Genetics award winner announced
6. Maynard Olson receives $500,000 Gruber Genetics Prize
7. Genetic defect links respiratory disease and congenital heart disease
8. Cell Press announces new partnership with the American Society of Human Genetics
9. Genetic fellow traveler discovered in Alzheimers
10. Genetic roots of bipolar disorder revealed by first genome-wide study of illness
11. Health disparities -- Genetics, society and race play an important role in access to healthcare

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Genetic defenders protect crops from fungal disease

(Date:5/21/2013)... at Chicago College of Medicine will study gender differences in ... energy source -- and how changes in fat metabolism play ... 4-year grant from the National Heart, Lung and Blood Institute. ... for energy. These changes may play a major role in ... and women, says E. Douglas Lewandowski, director of the UIC ...
(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...
(Date:5/20/2013)... is known about the effect of physical education (PE) ... University finds that increasing the amount of time that ... of obesity. , The study represents some of the ... youth obesity, and is forthcoming in the Journal ... of the study can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 ...
Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3Gym class reduces probability of obesity, study finds for first time 2
(Date:5/21/2013)... May 21, 2013 Alpha Source, ... , will be exhibiting for the 13th consecutive ... Medical Instrumentation (AAMI) 2013 Conference and Expo. The ... distribute, and manufacture healthcare technologies. This year’s event ... Beach, California. , The three-day event draws ...
(Date:5/21/2013)... Raleigh, NC (PRWEB) May 21, 2013 ... and financial services company for clinical trials, announced ... Aggregate Spend Solutions, LLC. Clinverse’s ClinPay® FLS ... automated investigator payment process. SpendMD ™, ... only complete solution for tracking and reporting transfer ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 As ... a strong push within the industry to deliver ... Manufacturing Organizations and pharma companies often means turning ... , Microtablets, developed in collaboration with Sensidose AB ... outsourcing can bring products to market sooner. The ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. ... study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal ... expressing the HER2 oncoprotein," will be presented at ... of Clinical Oncology during the Developmental Therapeutics - ... at 4:15 – 4:30 PM.  The presentation will ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: